Elamipretide · source year

Elamipretide research records in 2025

7 selected, source-linked Elamipretide records carrying a 2025 source date. This is a navigational view of PeptideScanner’s selected coverage—not a complete research timeline or a statement about safety or effectiveness.

Dated records

7 selected records.

Evidence types

3 represented types.

Cited sources

7 distinct public records.

Explore 2025 by evidence type

3 types

Cited chronology

Elamipretide records dated 2025

Open in the filterable feed →

December 2025

2 records

Regulatory

Federal Register notice 2025-23409

The Federal Register published notice 2025-23409, attributed to FDA and its parent HHS department, on 2025-12-19. Its official title is “Issuance of Priority Review Voucher; Rare Pediatric Disease Product; FORZINITY (Elamipretide),” and PeptideScanner's exact reviewed identity mapping connects the document to Elamipretide.

Source: Federal Register via GovInfo ↗

November 2025

1 record

Literature metadata

Elamipretide in the Management of Barth Syndrome: Current Evidence and a Case Report.

PubMed lists PMID 40816230 in Molecular genetics and metabolism as Journal Article, Case Reports, Review, with publication-date metadata of 2025-08-11 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

October 2025

1 record

July 2025

2 records

Literature metadata

Elamipretide for Barth syndrome cardiomyopathy: gradual rebuilding of a failed power grid.

PubMed lists PMID 34623544 in Heart failure reviews as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2021-10-08 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata

Targeting mitochondrial dysfunction with elamipretide.

PubMed lists PMID 35037146 in Heart failure reviews as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2022-01-17 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

February 2025

1 record

Literature metadata

Expanded-access use of elamipretide in a newborn with Barth syndrome: a case report.

PubMed lists PMID 39917770 in European heart journal. Case reports as Case Reports, Journal Article, with publication-date metadata of 2025-01-22 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗